Quarterly ResultMay 7, 2026, 04:24 PM
Sensus Healthcare Q1 Revenue $3.4M; CPT Codes Drive Pipeline
AI Summary
Sensus Healthcare reported a significant decrease in Q1 2026 revenue to $3.4 million from $8.3 million year-over-year, primarily due to the absence of sales to its historically largest customer and fewer units shipped. Despite this, the net loss remained stable at $2.6 million. The company highlighted the positive impact of new dedicated CPT Codes for Superficial Radiotherapy (SRT) effective January 1, 2026, which are driving increased customer activity, pipeline strength, and improved physician economics, alongside efforts to diversify its customer base and expand recurring revenue streams.
Key Highlights
- Q1 2026 revenue decreased to $3.4 million from $8.3 million year-over-year.
- Net loss was $2.6 million, or $0.16 per share, remaining flat year-over-year.
- Adjusted EBITDA was negative $4.2 million, compared to negative $2.5 million in Q1 2025.
- Dedicated CPT Codes for SRT and IG-SRT became effective January 1, 2026, improving physician economics.
- Shipped 14 SRT systems (10 direct, 4 placements) compared to 30 systems in Q1 2025.
- Cash and cash equivalents were $18.3 million with no debt as of March 31, 2026.
- Fair Deal Agreement program treatment volumes increased 8% over Q1 2025.